B cells emerge from the bone marrow as transitional (TS) B cells that differentiate through T1, T2, and T3 stages to become naive B cells. We have identified a bifurcation of human B cell maturation from the T1 stage forming IgMhi and IgMlo developmental trajectories. IgMhi T2 cells have higher expression of α4β7 integrin and lower expression of IL-4 receptor (IL4R) compared with the IgMlo branch and are selectively recruited into gut-associated lymphoid tissue. IgMhi T2 cells also share transcriptomic features with marginal zone B cells (MZBs). Lineage progression from T1 cells to MZBs via an IgMhi trajectory is identified by pseudotime analysis of scRNA-sequencing data. Reduced frequency of IgMhi gut-homing T2 cells is observed in severe SLE and is associated with reduction of MZBs and their putative IgMhi precursors. The collapse of the gut-associated MZB maturational axis in severe SLE affirms its existence in health.
CITATION STYLE
Tull, T. J., Pitcher, M. J., Guesdon, W., Siu, J. H. Y., Lebrero-Fernández, C., Zhao, Y., … Spencer, J. (2021). Human marginal zone B cell development from early T2 progenitors. Journal of Experimental Medicine, 218(4). https://doi.org/10.1084/JEM.20202001
Mendeley helps you to discover research relevant for your work.